en
Scientific article
Open access
English

GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78

Published inTargeted oncology, vol. 8, no. 4, p. 225-230
Collection
  • Open Access - Licence nationale Springer
Publication date2013
Abstract

Glucose-regulated protein 78, GRP78, is a chaperone protein mainly located in the endoplasmic reticulum (ER) of normal cells. In stress conditions, GRP78 is overexpressed and in different cancer cell types, it is expressed at the cell surface, whereas it stays intracellular in non-cancerous cells. Therefore, it appears as a strategic target to recognize malignant cells. Prostate cancer is one of the most diagnosed cancers in men. The development of castrate resistant tumors and the resistance to chemotherapy frequently occur. The carboxy-terminal ER retention domain is defined by the KDEL amino acid sequence. We developed anti-KDEL functionalized polymeric nanoparticles (NPs) loaded with paclitaxel (Tx) to specifically target prostate cancer cells expressing GRP78. The sensitivity to Tx in different formulations was compared in three prostate cell lines: PNT1B, a normal cell line, PC3, a cancer cell line faintly expressing GRP78 at its surface, and DU145, a cancer cell line expressing GRP78 at its cell surface. Our results show that the targeted formulation significantly increases Tx sensitivity of cell line expressing GRP78 at its surface compared to other treatments suggesting the added value of GRP78 targeted therapy for castrate resistant tumor which expresses GRP78 at its cell surface.

Citation (ISO format)
DELIE SALMON, Florence, PETIGNAT, Patrick, COHEN, Marie-Benoîte. GRP78-targeted nanotherapy against castrate-resistant prostate cancer cells expressing membrane GRP78. In: Targeted oncology, 2013, vol. 8, n° 4, p. 225–230. doi: 10.1007/s11523-012-0234-9
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1776-2596
632views
269downloads

Technical informations

Creation12/05/2013 8:40:00 AM
First validation12/05/2013 8:40:00 AM
Update time03/14/2023 8:41:46 PM
Status update03/14/2023 8:41:46 PM
Last indexation05/02/2024 1:32:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack